Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
J Seelig, MEW Hemels, O Xhaët… - … of thrombosis and …, 2020 - Wiley Online Library
Background The uptake rate of non–vitamin K oral anticoagulants (NOAC) for the treatment
of non‐valvular atrial fibrillation (AF) was far lower in the Netherlands (NL) compared to …
of non‐valvular atrial fibrillation (AF) was far lower in the Netherlands (NL) compared to …
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands
MS Jacobs, MWJ Van Leent, RG Tieleman… - Journal of Medical …, 2017 - Taylor & Francis
Aims: The prevalence of atrial fibrillation (AF) has increased over the past years due to aging
of the population, and healthcare costs associated with AF reflect a significant financial …
of the population, and healthcare costs associated with AF reflect a significant financial …
[PDF][PDF] 基于美国FDA 不良事件报告数据库的达比加群酯相关出血事件信号检测与分析
田晓江， 王晓莉， 王柯静， 陈琳 - 药物不良反应杂志, 2020 - cadrj.com
目的系统了解达比加群酯相关出血事件的发生情况, 为临床安全用药提供参考. 方法提取2004
年1 月至2019 年4 月美国FDA 不良事件报告系统(FAERS) 中首要怀疑药物为达比加群酯的 …
年1 月至2019 年4 月美国FDA 不良事件报告系统(FAERS) 中首要怀疑药物为达比加群酯的 …
Predicción de tiempo en rango terapéutico para pacientes con fibrilación auricular no valvular (FANV) anticoagulados con antivitamina k (AVK)
L Pérez Orero - 2023 - riunet.upv.es
[ES] Introducción: La fibrilación auricular (FA) es la arritmia cardiaca más frecuente y está
relacionada con eventos embólicos. La eficacia y seguridad de la anticoagulación con …
relacionada con eventos embólicos. La eficacia y seguridad de la anticoagulación con …
心房颤动患者血栓形成的影响因素分析
韩延辉， 王红雷， 来利红， 朱继红， 邢适颖… - 中国医学前沿杂志: 电子 …, 2016 - cqvip.com
目的探讨非瓣膜病性心房颤动(房颤) 患者发生左心房或左心耳血栓的危险因素. 方法选取2012
年1 月至2014 年1 月本院收治的130 例非瓣膜病性房颤患者为研究对象, 根据左心房或左心耳 …
年1 月至2014 年1 月本院收治的130 例非瓣膜病性房颤患者为研究对象, 根据左心房或左心耳 …
[HTML][HTML] Оптимизация фармакотерапии прямыми оральными антикоагулянтами: необходимость правильного выбора режима дозирования
АИ Кочетков, ОД Остроумова - Рациональная фармакотерапия в …, 2019 - cyberleninka.ru
В последние годы наблюдается стойкая тенденция ко все более частому назначению
прямых оральных антикоагулянтов (ПОАК) по сравнению с антагонистами витамина К в …
прямых оральных антикоагулянтов (ПОАК) по сравнению с антагонистами витамина К в …
Antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention
D Pan, X Ren, Z Hu - Current Pharmaceutical Design, 2018 - ingentaconnect.com
The optimal strategy of antithrombotic therapy for patients with atrial fibrillation (AF)
undergoing percutaneous coronary intervention remains to be a question to be answered …
undergoing percutaneous coronary intervention remains to be a question to be answered …
Separation and Identification of Four Tautomers (Hemiketals) of Acenocoumarol by HPLC-CD: Absolute Configuration, Simulation, and DFT Studies
I Ali, A Kraim, N Belboukhari, K Sekkoum… - papers.ssrn.com
Detection of tautomerization of acenocoumarol is an important issue in safe drug delivery.
Therefore, four stereoisomers (tautomers) were detected and separated using chiral HPLC …
Therefore, four stereoisomers (tautomers) were detected and separated using chiral HPLC …
No evidence for an association between renal function and serious bleeding events in patients treated with coumarins: a population-based study
E Houben, E Smits, JA Overbeek… - Annals of …, 2018 - journals.sagepub.com
Background: Although anticoagulation therapy is closely monitored in the Netherlands,
coumarin-induced serious bleeding events are still observed. Current literature suggests …
coumarin-induced serious bleeding events are still observed. Current literature suggests …
Health economics of direct oral anticoagulants in the Netherlands
L de Jong - 2020 - research.rug.nl
Blood thinners (anticoagulation) are used for the prevention of venous thromboembolism
and to prevent stroke in patients with atrial fibrillation. Vitamin K antagonists (VKAs) have …
and to prevent stroke in patients with atrial fibrillation. Vitamin K antagonists (VKAs) have …